The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Randomized Trial on Adjuvant Chemotherapy in Colon Carcinoma Dukes B
Official Title: A Prospectively Randomized Study on Adjuvant Chemotherapy in Patients With Operated Colon Carcinoma Dukes B (Stage II; T3-4, N0, M0).
Study ID: NCT00309543
Brief Summary: This clinical investigation examined the influence of cytostatic chemotherapy with 5-fluorouracil, modulated by biologically active leucovorin, on patients' survival time following surgery for colon carcinoma Stage II.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Hospital Guessing, Guessing, Burgenland, Austria
Hospital Oberpullendorf, Oberpullendorf, Burgenland, Austria
Hospital BHB St. Veit/Glan, Surgery, St. Veit a. d. Glan, Carinthia, Austria
State Hospital Wolfsberg, Wolfsberg, Carinthia, Austria
Hospital Hainburg, Hainburg, Lower Austria, Austria
Hospital Krems, Krems, Lower Austria, Austria
Hospital Tulln, Tulln, Lower Austria, Austria
Hospital Waidhofen/Thaya, Waidhofen a. d. Thaya, Lower Austria, Austria
Hospital Wiener Neustadt, Surgery, Wiener Neustadt, Lower Austria, Austria
Medical University of Graz, Oncology, Graz, Styria, Austria
State Hospital Leoben, Leoben, Styria, Austria
Hospital St. Vinzenz, Zams, Tyrol, Austria
State Hospital Kirchdorf, Kirchdorf, Upper Austria, Austria
Hospital Kreuzschwestern Wels, Wels, Upper Austria, Austria
State Hospital Feldkirch, Feldkirch, Vorarlberg, Austria
Paracelsus Medical University Salzburg - Oncology, Salzburg, , Austria
Medical University Vienna, General Hospital, Vienna, , Austria
Wilheminenspital, Internal Medicin I, Vienna, , Austria
Name: Raimund Jakesz, MD
Affiliation: Austrian Breast & Colorectal Cancer Study Group
Role: PRINCIPAL_INVESTIGATOR